What Is the AbbVie CEO-to-Worker Pay Ratio?
AbbVie's CEO-to-worker pay ratio is 120:1 — CEO Robert Michael earned $12.0M in 2025, or 120 times the median AbbVie employee's pay of $100,000. That is below the S&P 500 median of roughly 300:1.
This page answers a common executive-compensation question: What Is the AbbVie CEO-to-Worker Pay Ratio?. The answer draws on SEC DEF 14A proxy statements, the public disclosure mechanism for U.S. public-company executive pay. Every public company must file an annual proxy statement disclosing CEO and named-executive-officer compensation in detail. Why this matters for shareholders: executive compensation is the single most-disclosed governance metric at U.S. public companies, and the Dodd-Frank-mandated say-on-pay vote gives shareholders an explicit channel to express approval or dissent. Reading pay data well — including pay-versus-performance, peer-group selection, and time-vesting structures — is a basic part of stock-by-stock fundamental analysis.
The detailed answer below uses the actual proxy-statement filings, explains how to read them, and translates the executive-compensation accounting into the shareholder-relevant interpretation.
AbbVie Pay Ratio Breakdown
- CEO-to-worker ratio
- 120:1
- CEO total comp
- $12.0M
- Median worker pay
- $100,000
- S&P 500 median ratio
- ~300:1
- Employees
- 50,000
- Pay-Performance grade
- B
Source: AbbVie SEC DEF 14A proxy statement (Dodd-Frank §953(b) pay-ratio disclosure). S&P 500 median is an industry benchmark.
Public companies have been required to disclose the ratio of CEO pay to median-employee pay in their proxy statements since 2018, under Section 953(b) of the Dodd-Frank Act. At AbbVie, Robert Michael's $12,000,000 total compensation works out to 120 times the $100,000 earned by the company's median employee — a Pharmaceuticals workforce of roughly 50,000 people.
For context, the typical S&P 500 CEO-to-worker pay ratio runs near 300:1, so AbbVie's 120:1 figure is lower than the large-cap norm. The ratio is driven mostly by equity: Robert Michael received $6,000,000 in stock awards and $1,440,000 in option awards in 2025, versus $1,200,000 in base salary. Median worker pay reflects total cash and benefits for the employee at the 50th percentile of the company's global workforce.
Whether a high ratio is "fair" is contested. Critics argue wide gaps signal misaligned incentives and weak labor bargaining power; defenders argue CEO pay is mostly performance-linked equity that only pays out if shareholders gain. AbbVie's three-year total shareholder return of 2.5% and Pay-for-Performance grade of B (65/100) are the data points to weigh that against.
In the most recent say-on-pay vote, 87.2% of shareholders approved the executive compensation plan. Moderate shareholder support suggests some investor concern with pay practices.
Pay Ratio Inputs
| Component | Amount |
|---|---|
| Total Compensation | $12,000,000 |
| Base Salary | $1,200,000 |
| Stock Awards | $6,000,000 |
| Option Awards | $1,440,000 |
| Median Worker Pay | $100,000 |
| CEO-to-Worker Pay Ratio | 120:1 |
| Pay-Performance Grade | B |
Other Pharmaceuticals CEOs
Frequently Asked Questions
AbbVie's CEO-to-worker pay ratio is 120:1. CEO Robert Michael earns approximately 120 times the median worker's pay of $100,000, as disclosed in the company's SEC DEF 14A proxy statement.
The typical S&P 500 CEO-to-worker pay ratio is around 300:1. AbbVie's 120:1 figure is below that benchmark.
The ratio is driven mainly by equity. Robert Michael received $6,000,000 in stock awards and $1,440,000 in option awards in 2025, against base salary of $1,200,000. The median AbbVie employee earns $100,000.
Robert Michael, CEO of AbbVie, earned $12.0M in total compensation in 2025, including $6.0M in stock awards and $1,200,000 in base salary.
Robert Michael is the chief executive officer of AbbVie (ABBV).
Our Pay-for-Performance Score rates AbbVie as B (65/100), based on three-year total shareholder return of 2.5%, revenue growth of 6.1%, and shareholder say-on-pay vote approval.
More about AbbVie
AbbVie's CEO-to-worker pay ratio is 120:1 — CEO Robert Michael earned $12.0M in 2025, or 120 times the median AbbVie employee's pay of $100,000. That is below the S&P 500 median of roughly 300:1.
Source: SEC EDGAR DEF 14A proxy statements, 2026.